Ethnic distribution of HLA-DQ2 and HLA-DQ8 alleles in celiac disease with serological confirmation: A cross-sectional study from a tertiary care center in Rawalpindi
DOI:
https://doi.org/10.55629/pakjpathol.v37i2.948Abstract
Objective: To determine the ethnic distribution of HLA-DQ2 and HLA-DQ8 alleles among Pakistani patients with serologically confirmed celiac disease (CD).
Material and Methods: This cross-sectional study was conducted at the Department of Immunology, Armed Forces Institute of Pathology (AFIP), Rawalpindi, from 1st September 2021 to 30th September 2022. A total of 100 serologically confirmed CD patients were enrolled through consecutive non-probability sampling. Anti-tissue transglutaminase IgA was tested by ELISA (Diametra, Italy), while total serum IgA was measured to exclude IgA deficiency. Genomic DNA was extracted from EDTA blood using the Puregene® Blood Core Kit B (QIAGEN, Germany), and HLA typing was performed by sequence-specific primer PCR. Data were analysed using SPSS v26.0.
Results: HLA-DQ2 was detected in 92 (92.0%) and HLA-DQ8 in 7 (7.0%) of 100 patients; only 1 patient (1.0%), from the Pathan group, was negative for both. HLA-DQ2 prevalence was 100% in Kashmiri (n=13) and Gilgit-Baltistani (n=9) patients, 94.9% (37/39) in Punjabis, 90.0% (9/10) in Sindhis, 83.3% (20/24) in Pathans, and 80.0% (4/5) in Balochis. HLA-DQ8 was most prevalent in Balochis (20.0%, 1/5) and Pathans (12.5%, 3/24). HLA-DQ2 was the dominant allele across all ethnic groups.
Conclusion: HLA-DQ2 is the dominant celiac-associated allele across all major Pakistani ethnic groups, with universal prevalence in Kashmiri and Gilgit-Baltistani populations. HLA-DQ8 is most frequent in Balochi and Pathan subgroups. HLA genotyping supports diagnostic evaluation across ethnically diverse Pakistani communities.
Keywords: Celiac disease, Ethnicity, Genetic susceptibility, HLA-DQ2 Antigen, HLA-DQ8 Antigen.
References
Singh P, Arora A, Strand TA, Leffler DA, Catassi C, Green PH, et al. Global prevalence of celiac disease: systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2018; 16(6): 823–836.e2. DOI: https://doi.org/10.1016/j.cgh.2017.06.037
Iversen R, Sollid LM. The immunobiology and pathogenesis of celiac disease. Annu Rev Pathol. 2023; 18: 47–70.
DOI: https://doi.org/10.1146/annurev-pathmechd is-031521-032634
Poddighe D, Rebuffi C, De Silvestri A, Capittini C. Carrier frequency of HLA-DQB1*02 allele in patients affected with celiac disease: a systematic review assessing the potential rationale of a targeted allelic genotyping as a first-line screening. World J Gastroenterol. 2020; 26(12): 1365–81. DOI: https://doi.org/10.3748/wjg.v26.i12.1365
Al-Toma A, Volta U, Auricchio R, Castillejo G, Sanders DS, Cellier C, et al. European Society for the Study of Coeliac Disease (ESsCD) guideline for coeliac disease and other gluten-related disorders. United European Gastroenterol J. 2019; 7(5): 583–613. DOI: https://doi.org/10.1177/2050640619844125
Sarno M, Discepolo V, Troncone R, Auricchio R. Risk factors for celiac disease. Ital J Pediatr. 2015; 41: 57. DOI: https://doi.org/10.1186/s13052-015-0166-y
Alam M, Tipu HN, Ahmad D, Hussain M, Khalid UB, Ijaz Y. HLA-DQ2 and HLA-DQ8 alleles in celiac disease patients and healthy controls. J Coll Physicians Surg Pak. 2022; 32(2): 157–60. available from: https://www.jcpsp.pk/oas/mpdf/ge nerate_pdf.php?string=cGdkR0t1a1E4eHFqc21rMDNQVUowUT09
Husby S, Koletzko S, Korponay-Szabó I, Kurppa K, Mearin ML, Ribes-Koninckx C, et al. European Society Paediatric Gastroenterology, Hepatology and Nutrition guidelines for diagnosing coeliac disease 2020. J Pediatr Gastroenterol Nutr. 2020; 70(1): 141–56. DOI: https://doi.org/10.1097/mpg.0000000000002497
Shamraiz I, Naz S, Idrees S, Ikram F, Khan H, Khan S. Human leukocyte antigen (HLA) DQ2 and DQ8 haplotypes in children with celiac disease. Pak Armed Forces Med J. 2025; 75(1): 199–204. DOI: https://doi.org/10.51253/pafmj.v75i1.10651
Gudeta AN, Ramelius A, Balcha TT, Girma A, Ilonen J, Agardh D. Distribution of HLA-DQ risk genotypes for celiac disease in Ethiopian children. HLA. 2020; 96(6): 681–87. DOI: https://doi.org/10.1111/tan.14119
Khosravi A, Mansouri M, Rostami-Nejad M, Shahbazkhani B, Ekhlasi G, Kalantari E. The likelihood ratio and frequency of DQ2/DQ8 haplotypes in Iranian patients with celiac disease. Gastroenterol Hepatol Bed Bench. 2016;9(1):18–24. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC4702037/pdf/GHFBB-9-18.pdf
Elwenspoek MMC, Thom H, Sheppard AL, Keeney E, O'Donnell R, Jackson J, et al. Defining the optimum strategy for identifying adults and children with coeliac disease: systematic review and economic modelling. Health Technol Assess. 2022; 26(44): 1–310. DOI: https://doi.org/10.3310/zuce8371
Aboulaghras S, Piancatelli D, Taghzouti K, Balahbib A, Alshahrani MM, Al Awadh AA, et al. Meta-analysis and systematic review of HLA DQ2/DQ8 in adults with celiac disease. Int J Mol Sci. 2023; 24(2): 1188. DOI: https://doi.org/10.3390/ijms24021188
Mardini HE, Westgate P, Grigorian AY. Racial differences in the prevalence of celiac disease in the US population: National Health and Nutrition Examination Survey (NHANES) 2009–2012. Dig Dis Sci. 2015; 60(6): 1738–42
DOI: https://doi.org/10.1007/s10620-014-3514-7
Lebwohl B. Celiac disease and the forgotten 10%: the "silent minority". Dig Dis Sci. 2015; 60(6): 1517–18. DOI: https://doi.org/10.1007/s10620-015-3572-5
Mansouri M, Dadfar M, Rostami-Nejad M, Ekhlasi GH, Shahbazkhani AH, Shahbazkhani B. The frequency of HLA-DQ2/DQ8 haplotypes and celiac disease among the first-degree relatives of patients with celiac disease. Gastroenterol Hepatol Bed Bench. 2021; 14(1): 36–43. DOI: https://doi.org/10.22037/ghfbb.v14i1.1922
Cerda-Contreras E, Ramírez-Cervantes KL, Granados J, Mena L, Núñez-Álvarez C, Uscanga L. Is celiac disease better identified through HLA-DQ8 than HLA-DQ2 in Mexican subjects? Rev Gastroenterol Mex (Engl Ed). 2018; 83(4): 410–3. DOI: https://doi.org/10.1016/j.rgmx.2018.01.005
Schirru E, Rossino R, Jores RD, Corpino M, Muntoni S, Cucca F, et al. Clinical settings in which human leukocyte antigen typing is still useful in the diagnosis of celiac disease. World J Gastroenterol. 2025; 31(14): 104397. DOI: https://doi.org/10.3748/wjg.v31.i14.104397
Sallese M, Lopetuso LR, Efthymakis K, Neri M. Beyond the HLA genes in gluten-related disorders. Front Nutr. 2020; 7: 575844. DOI: https://doi.org/10.3389/fnut.2020.575844
Erlichster M, Bedo J, Skafidas E, Kwan P, Kowalczyk A, Goudey B. Improved HLA-based prediction of coeliac disease identifies two novel genetic interactions. Eur J Hum Genet. 2020; 28(12): 1743–52. DOI: https://doi.org/10.1038/s41431-020-0700-2
Çakır M, Baran M, Uçar F, Akbulut UE, Kaklıkkaya N, Ersöz Ş. Accuracy of HLA-DQ genotyping in combination with IgA anti-tTG serology and a scoring system for diagnosis of celiac disease in Turkish children. Turk J Pediatr. 2014; 56(4): 347–53. Available from: https://turkjpediatr.org/article/view/ 1382/1375
Jamnik J, Villa CR, Dhir SB, Jenkins DJA, El-Sohemy A. Prevalence of positive coeliac disease serology and HLA risk genotypes in a multiethnic population of adults in Canada: A cross-sectional study. BMJ Open. 2017; 7(10): e017416. DOI: https://doi.org/10.1136/bmjopen-2017-017416
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 mustajab alam, Muhammad Hussain, Muhammad Zain ul Abdeen Javed, Dr fatima Sharif

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Readers may “Share-copy and redistribute the material in any medium or format” and “Adapt-remix, transform, and build upon the material”. The readers must give appropriate credit to the source of the material and indicate if changes were made to the material. Readers may not use the material for commercial purpose. The readers may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
